These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31919337)

  • 1. Diagnostic Challenges and Treatment Options for Cutaneous T Cell Pseudolymphoma: A Case Study with Rituximab Treatment.
    Balode D; Beļajeva L; Ruesseler V; Quaas A; Lejniece S
    Am J Case Rep; 2020 Jan; 21():e919616. PubMed ID: 31919337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab.
    Martin SJ; Duvic M
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):286-8. PubMed ID: 21658657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneus pseudolymphoma: a case report.
    Dragonetti E; Cianchini G; Mastrangelo L; Mellone P; Baldi A
    In Vivo; 2004; 18(5):549-51. PubMed ID: 15523891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous lymphoid hyperplasia (pseudolymphoma).
    Zhou LL; Mistry N
    CMAJ; 2018 Apr; 190(13):E398. PubMed ID: 29615424
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab.
    Witzig TE; Inwards DJ; Habermann TM; Dogan A; Kurtin PJ; Gross JB; Ananthamurthy A; Ristow KM; Garity JA
    Mayo Clin Proc; 2007 Jun; 82(6):692-9. PubMed ID: 17550749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous intravascular CD30+ T-cell pseudolymphoma occurring in a regressing keratoacanthoma.
    Kailas A; Elston DM; Crater SE; Cerruto CA
    J Cutan Pathol; 2018 Apr; 45(4):296-298. PubMed ID: 29369392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Pseudolymphoma With Langerhans Cell Hyperplasia-A Rare Case With Clinical Presentation Mimicking Malignancy and Potential Diagnostic Pitfall.
    Ye CH; Chen CJ; Chang KC; Wu YH; Chen ML; Chiu TM
    Am J Dermatopathol; 2021 Dec; 43(12):e280-e284. PubMed ID: 34001745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
    Bergman R
    Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Pseudolymphoma Due to Hirudotherapy.
    Temiz SA; Özer İ; Ataseven A; Dursun R; Fındık S
    Turkiye Parazitol Derg; 2019 Mar; 43(1):50-52. PubMed ID: 30938141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma.
    Singletary HL; Selim MA; Olsen E
    Arch Dermatol; 2012 May; 148(5):572-4. PubMed ID: 22782150
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiopathic Cutaneous Pseudolymphoma Treated Successfully with Hydroxychloroquine: A Case Report and Literature Review.
    Mizuno H; Takahagi S; Morita S; Kamegashira A; Tanaka A
    Acta Derm Venereol; 2022 Oct; 102():adv00798. PubMed ID: 36250760
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous pseudolymphoma with rhinophyma-like lesion.
    Oginezawa M; Kawai K
    J Dermatol; 2019 Sep; 46(9):e335-e337. PubMed ID: 30951205
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
    Han B; Liu H; Wang H
    Dermatol Ther; 2022 Nov; 35(11):e15812. PubMed ID: 36088631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variability and diagnostic limitations in cutaneous pseudolymphoma].
    Bagot M
    Ann Dermatol Venereol; 2008 Nov; 135(11):729-30. PubMed ID: 19061649
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous pseudolymphoma: an unusual eyelid presentation.
    Cloke A; Lim LT; Crofts KP
    Semin Ophthalmol; 2012; 27(1-2):35-6. PubMed ID: 22352826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood cutaneous lymphoid hyperplasia following feline scratches.
    Madhogaria S; Carr RA; Gach JE
    Pediatr Dermatol; 2010; 27(3):294-7. PubMed ID: 20609149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists].
    Levy E; Godet J; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2013 Feb; 140(2):105-11. PubMed ID: 23395491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
    Magro CM; Momtahen S
    Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis between cutaneous lymphoma and pseudolymphoma.
    Cerroni L; Goteri G
    Anal Quant Cytol Histol; 2003 Aug; 25(4):191-8. PubMed ID: 12961825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous pseudolymphoma secondary to gabapentin.
    Newman AJ; Mullens D; Pulford C; Lam T
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30344158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.